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RESUMEN 
Estudio sobre el efecto de la vanillina (aditivo alimen-
tarlo) en algunas reacciones metabólicas de animales 
experimentales. 
Se administró vanillina (4-h¡drox¡-3-metoxibenzaldeh¡do) a 
ratas albino hipercolesterolémicas en dosis bajas y altas (1,0 
y 2,0% respectivamente) por un período de nueve semanas. La 
forma lipídica así como las funciones hepáticas y renales se 
determinaron en ratas normales, hipercolesterolémicas e hiper-
colesterolémicas a las que se les administró vanillina. La 
hipercolesterolemia se caracterizó por un aumento significativo 
en los niveles medios de lípidos totales, colesterol total y tri-
glicéridos, y una disminución significativa en el contenido de 
fosfolípidos. También, la función hepática (S.GOT, S.GPT, 
alcalina y ácido fosfatasa) así como las funciones renales se 
elevaron en comparación con el grupo control. La administra-
ción de vanillina redujo significativamente los lípidos totales de 
hígado y ríñones. El bazo y corazón siguieron la misma tenden-
cia pero con efecto moderado, mientras que el cerebro no se 
afectó. 
El colesterol total en hígado, ríñones, bazo y corazón 
disminuyó significativamente, en tanto que en cerebro no se 
afectó. 
Los triglicéridos disminuyeron significativamente en hígado 
y bazo, mientras que no se alteraron en ríñones y cerebro. 
También hubo una disminución significativa en la alta 
actividad de S.GOT, S.GPT, alcalina y fosfatasa acida y se 
alcanzaron valores muy próximos al nivel inicial. La administra-
ción de vanillina ejerció efectos anabólicos potentes para el 
metabolismo de proteínas como se demuestra de los resultados 
del ácido urónico y creatinina. 
PALABRAS-CLAVE: Aditivo alimentario - Rata - Reacción 
metabólica - Vanillina (efecto de), 
SUMMARY 
Studies on the effect of vanillin (food additive) on some 
metabolic reactions of the experimental animals. 
Vanillin (4-hydroxy-3-methoxybenzaldehyde) was adminis-
trated to hypercholesterolemic albino rats at low and high doses 
(1.0 and 2.0%, respectively) for nine weeks period. Lipid pat-
tern, as well as liver and kidneys functions were determined in 
normal, hypercholesterolemic and hypercholesterolemic rats ad-
ministrated vanillin. Hypercholesterolemia was characterized by 
significant increase in the average levels of total lipids, total 
cholesterol and triglycerides and a significant decrease in 
phospholipids content. Also, liver function (S.GOT, S.GPT, alkaline 
and acid phosphatase) as well as kidneys function were eleva-
ted compared to control group. Administration of vanillin signi-
ficantly reduced liver and kidneys total lipids. Spleen and heart 
followed nearly the same trend but with moderate effect, while 
brain was not affected. Liver, kidneys, spleen and heart total 
cholesterol was significantly reduced while brain total choleste-
rol was not affected. Triglycerides were significantly decreased 
in liver and spleen, while that of kidneys and brain was not 
affected. Also, there was a significant decrease in the high ac-
tivity of S.GOT, S.GPT, alkaline and acid phosphatase and the 
values were nearly attained to the initial level. Administration of 
vanillin exertes potent anabolic effects for protein metabolism as 
shown from the results of uric acid and creatinine. 
KEY-WORDS: Food additive - Metabolic reactions - Rat -
Vanillin (effect of). 
1 . INTRODUCTION 
Cholesterol presents a great health hazard when 
its consunnption is unduely increased. Hyperlipae-
nnia is a gross derangement in metabolism starting 
from the rare hereditary hypercholesterolemia up 
to the widespread adult condition. Hypercholeste-
rolemic arteriopathies whether coronary or cere-
bral take the bigest tool of middle aged and elderly 
deaths (1). Regarding the etiological factors of 
hypercholesterolemia, this syndrome still remains 
to be dealt with as a biochemical entity in a trial 
to correct it as well as to judge for the success or 
failure of the medications used as thereapeutic 
agents. Nowadays, biochemists, pharmacologists 
and physicians, among other investigators are 
always looking for more effective hypocholestero-
lemic agents. Although some of their results may 
prove to be satisfactory, yet the uttery successful 
medicament has not been discovered. The present 
work is an attempt to evaluate the potency of vanillin 
as hypocholesterolemic agent in the treatment of 
hypercholesterolemic rats. It was intended that the 
results of these studies well aid in the selection of 
new sources which combines the efficiency and 
safety in the treatment of hypercholesterolemia and 
hyperlipaemia. 
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2. MATERIALS AND METHODS 
2.1. Material 
Vanillin , (4-hydroxy-3-methoxy benzaldehyde) 
was obtained from Aldrich Chem. Company, Inc. 
USA. 
2.2. Animals, Diets and Treatments 
to Lee and Takabashi (9). Serum glutamate-pyru-
vate and glutamate oxaloacetate transaminases (S. 
GPT and S. GOT) (Ritman and Frankel, (10)). 
Alkaline phosphatase (King and King, (11)), total 
serum protein (Lowary et al., (12)), serum albumin 
and globulin (Peter, (13)) serum uric acid (Cara-
way, (14)) creatinine (Chasson et al., (15)) statis-
tical analysis [t-test (Snedechor and Cochran (16))]. 
All the procedures were determined routinelly 
according to the methods in brackets. 
A total of ninety six, 60 days old male albino 
rats weighing 100-120 g were kept under normal 
healthy laboratory conditions and fed normal diet 
which consisted of casein 15%, cotton seed oil 10%; 
cellulose 5%, salt mixture 4% (Hegested et al. (2)), 
vitamin mixture 1 % (Campbell, (3)) and corn starch 
65% ad libitum for two weeks (adaptation period). 
The animals were divided randomly into two groups. 
Animals in group I (24 rats) were continued fee-
ding on the basal diet and served as negative 
control. Animals in group II (72 rats) were subjec-
ted to a hypercholesterolemic regime for a period 
of 12 weeks.- Induction of hypercholesterolemia in 
the experimental animals was employed using the 
method of Abdel-Raheim et al. (4) using choleste-
rol and choleic acid mixture. During this period, 
blood samples from the individual rats were collec-
ted via the puncture of retobulber venous plexus 
by a fine cappillary glass tube every three weeks 
to determine the levels of all lipid fractions to 
achieve hypercholesterilemia. After this period the 
hypercholesterolemic rats were divided into three 
subgroups II a, II b and II c. Rats in subgroup II 
a was continued feeding on the hypercholestero-
lemic regimen and served as hypercholesterolemic 
control (positive control). Rats in the other two 
subgroups were also continued feeding on hyper-
cholesterolemic regimen but were administrated low 
and high dose of vanillin (1.0 and 2.0% respecti-
vely at the expense of starch) for a period of nine 
weeks and every three weeks six rats of each group 
or subgroup were killed by decapitation. Blood, liver, 
kidnyes, brain, spleen and heart were removed and 
chilled for further processes. 
2,3. Enzymes and metabolits assays 
Total lipids, total cholesterol, triglycerides and 
phospholipids, in all studied organs were determi-
ned according to Knight et al. (5), Chaurchami et 
al. (6), Fletcher (7) and Bartlett (8), respectively. 
Total free amino acids were determined according 
3. RESULTS AND DISCUSSION 
In the present investigation the induction of 
hypercholesterolemia in the experimental animals 
was the first practical objective in order to evaluate 
the response of lipid pattern to Vanillin induction. 
The level of normal lipid pattern of rats used in the 
present study was evaluated prior to the initiation 
of the experiment and after the induction of hyper-
cholesterolemia and then after administrating 
Vanillin at 1 % and 2% doses at the expense of 
starch for nine weeks period and the results are 
given in Tables I, II and III. 
Data in Table I indicated that the average level 
of blood total lipids was elevated from 326 to 815 
mg/dL after 12 weeks of administrating of the hyper-
cholesterolemic mixture and to 922 mg/dL at the 
end of the experimental period (21 weeks). Blood 
cholesterol represents the main item under inves-
tigation. The pre experimental level was 116.11 
and the final level was 280.6 mg/dL after 12 weeks 
of administration of the hypercholesterolemic 
mixture. Another conspicuous level of 385.2 mg/dL 
was attained after 21 weeks in the cholesterol 
loaded animals. The triglyceride level showed a 
regular rise from the normal value of 44.6 to 184.6 
mg/dL after 12 weeks, and to 235.9 mg/dL after 
21 weeks feeding of hypercholesterolemic diet. It 
is stated that triglycerides represent a synchronous 
rise with that of cholesterol. Boxer, et al. (17). Also, 
data in Table I demonstrated that there was a pro-
gressive decline in the level of.blood phospholipids 
from initial value of 118.6 mg/dL to 82.6 mg/dL 
after 12 weeks of the start of experiment. The phosp-
holipids hepatic storage in hypercholesterolemia 
seem to be the factor involved in the progressive 
decline in blood phospholipids, Tawfic (18). As 
shown in Table I administration of Vanillin showed 
a marked progress in the correction of lipid cho-
lesterol complex, in spite of the continued choles-
terol loading during the treatment. After nine weeks 
of treatment with Vanillin, the level of serum total 
lipids was declined from 922 to 470 and 415 mg/ 
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dL. The cholesterol level decreased from 385.2 to 
161.7 and 146.5 mg/dL. It appears that the ave-
rage level of triglycerides which amounted to 235.9 
mg/dL in the pretreatment level was lowered to 
84.2 and 81.4 mg/dL. The level of phospholipids, 
however was increased from 42.0 to 98.6 and 102.5 
respectively. 
The administration of cholesterol and cholic acid 
mixture during the treatment with Vanillin was 
carried out primarily in order to abolish the pos-
sibility of self curing after the withdrawlal of these 
drugs. It is also well established that hypercholes-
terolemia in human is a combination of a dietary 
and endogenous factors in lipid metabolism. 
Therefore the state continuous in human during 
the treatment with the hypocholesterolemic agent, 
the continuation of cholesterol administration in 
therefore closer to the natural state of events. 
The effect of vanillin on the lipid pattern was 
also studied in the different rat organs before and 
after treatment. As shown in Tables I, II and III 
there were some rises of all lipids fractions of the 
normal rats. This may be due to life span of the 
rats which is extremely short, so the age of rats 
may be a factor affecting the results especially if 
we consider that the experimental period lasted for 
21 weeks. On the other hand hypercholesterole-
mia was characterized by significant increase in 
the average levels of total lipids, total cholesterol 
and triglycerides and a significant decrease in 
phospholipids as compared with the corresponding 
values of the untreated rats. Total lipids in liver 
was significantly increased compared with negati-
ve control during the induction period. Total lipids 
in brain, kidneys and spleen was not affected, while 
that of heart was slightly increased. Triglycerides 
also, showed a high significant increase in liver 
and kidneys while that of heart was slightly increa-
sed but in brain was not affected. Total cholesterol 
in liver, brain kidneys, spleen and heart was sig-
nificantly increased upon administrating mixture of 
cholesterol and cholic acid. The liver was charac-
terized by high cholesterol content. The hypercho-
lesterolemic state was associated with a general 
decrease in liver and kidneys phospholipids, while 
that of brain was nearly unaffected. These results 
concerning hypercholesterolemic state are in agree-
ment with Said (19) and El-Saadany et al., (20-
21). 
The value of administrating Vanillin in low and 
high doses (1.0 and 2.0%, respectively at the 
expense of starch) to hypercholesterolemic rats 
show that. Vanillin significantly reduced, liver and 
kidneys total lipids. Total lipids in spleen and heart 
followed the same trend but with moderate effect 
while that of brain was not affected. Liver, kidney. 
spleen and heart total cholesterol was significantly 
reduced, while that of brain was also not affected, 
despite the continued cholesterol and cholic acid 
loading. Triglycerides also were significantly de-
creased in liver and spleen and slightly decreased 
in the heart while that of kidneys and brain was 
not affected by Vanillin administration. Triglyceri-
des are normally formed by single esterification of 
circulating fatty acids from adipose tissues and 
newly produced fatty acids rived from dietary 
sources. The increase in triglycerides levels thus 
may be due to either the increase of lipogenesis 
process or to the decrease in its removal from 
plasma to impairement of lipoprotein activity. The 
latter case has been formed to decline after 
administration of Vanillin in both low or high doses. 
The obtained results are similar with that obtained 
by Abdel-Rheim, et al. (4) and El-Saadany et al., 
(20-21) who studied the hypocholesterolemic ef-
fect of Balanetus aegvptica fruits, Karkade and 
Cassia fistula, respectively, on hypercholesterole-
mic albino rats. The hypocholesterolemic action of 
Vanillin may be due to the phenolic structure of 
such compound. 
To study safety of such compound to be used 
as food additive, liver function as well as kidneys 
function were determined before, during and after 
administration (every three weeks) and the results 
are given in Tables IV, V and VI. 
As shown in Table IV hypercholesterolemia was 
characterized by significant increase in G P T. The 
increase attained about 1.5 fold that of normal rats. 
The increase of acid phosphatase was more pro-
nounced than that of alkaline phosphatase. Also, 
its effect on G P T was more pronunced than that 
of GOT. The increase in GPT activity indicate liver 
cell necrosis. The increase of GOT activity was 
less specific for hepatic injury. These results are 
in agreement with those obtained by El-Saadany 
et al. (20-21). 
Increasing the activity of transaminase may stem 
from the second amino group of urea which enters 
the urea cycle arriving \n the form of aspartate. 
GOT play a remarkable role as shown: 
GOT 
Glutamic + Oxalacetic >a-Ketoglutaric + aspartate 
The amino group of aspartate condeses with 
the carbonyl carbon atom of citruline in the pre-
sence of ATP, to form argininosuccinate which re-
versibly cleaved by argininosuccinase to form ar-
ginine and fumarate. Fumarate and a-Ketoglutara-
te formed return to the pool of tricarboxylic acid 
cycle (TCA) intermediates. Also, the production of 
a-Ketoglutaric acid was stimulated by increasing 
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Table I : Effect of administrating Vaniline on serum and liver lipids pattern of hypercholesterolemic rats. 
Total lipids mg % 
Treatments 
Cholesterol mg % Phospholipids mg % Triglycerides mg % 
Time in weeks 
< 
ft) 
0) p 
CD 
CD 
326* 
Negative control 
345* 337* 
+ 2 1 . 4 + 2 2 . 5 + 2 0 . 6 
116.11* 121.13* 139.6* 
+ 9.7 + 11.4 + 13.5 
118.6* 115.3* 114.9* 44.6* 45.4* 47.2* 
+ 10.6 + 9.9 + 10.4 + 3..56 + 4.32 + 3.62 
Positive control 
Low dose 1% 
High dose 2% 
815 
+ 70.4 
812 
+ 75.6 
800 
+ 68.1 
874 
+ 72.7 
672* 
+ 51.6 
624* 
+ 54.9 
922 
+ 63.5 
470.2* 
+ 43.5 
415.9* 
+ 40.6 
280.6 
• 27.3 
240.5 
• 2 0 . 5 
329 
+ 30.4 
220.5* 
+ 18.61 
385.2 
+ 32c6 
161.7* 
+ 14.5 
284.6 195.36* 146.5^ 
f 23.4 + 16.4 + 10.8 
82.6 53.6 
8.0 + 5.2 
42.0 184.6 212.4 235.9 
+ 3.6 + 17.4 + 16.4 + 18.5 
82.1 86.9* 98.6* 180.5 136.2* 84.2* 
7.21 + 4.60 + 6.32 + 15.4 + 11.6 + 7.2 
78.2 92.7* 
7.04 + 6.92 
102.5* 178.2 142.5* 81.4* 
f 9.52 + 15.3 + 9.24 + 6.45 
5.91* 6.02* 6.01* 
Negative control 
Positive control 
Low dose 1% 
+ 0.52 + 0.58 + 0.26 
250* 
f 23.6 
13.65 15.89 16.02 1182 
+ 1.21 + 1.42 + 1.56 +90.4 
13.14 11.64* 9.95* 892 
+ 1.21 + 0.86 + 0.46 +68.7 
2531.4* 
+ 22.56 
1340 
+120.4 
790* 
+ 64.8 
259.4* 
+ 20.3 
1385 
+126.5 
650* 
+ 52.7 
302.5* 
+ 22.4 
204.2 
+ 20.2 
207 
+ 19.9 
301.6* 
+ 30.0 
185 
+ 16.4 
239* 
+ 18.5 
307.0* 4.51* 4.25* 4.60*" 
f 29.6 + 0.30 + 0.28 + 0.36 
172.3 9.72 
f 11.4 + 0.81 
285* 9.47 
f 19.45 + 0.92 
10.45 11.64 
+ 0.96 + 1.04 
7.64* 5.92 
+ 0.65 . + 0.51 
High dose 2% 
13.05 11.56* 9.70* 872 752* 602* 
+ 1.23 + 1.02 + 0.64 + 74,5 + 68.9 + 60.10 
198 242.6* 
+ 12.6 + 12.56 
296.4* 9.56 7.72* 5.46^ 
+ 19.91 + 0.51 + 0.65 + 0.24 
•Values are significant relative to positive control (P<0.01). 
In liver total lipids and triglycerides are expressed as g./lOOg. CO 
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Table II : Effect of administrating Vaniline on kidneys and brain lipids pattern of hypercholesterolemic rats. 
Treatments 
Total lipids 
gm/100 gm 
Cholesterol mg/100 gm Phospholipids mg/100 gm 
Time in weeks 
Triglyceride 
gm/100 gm 
4^ 
CO 
Negative control 
Positive control 
Low dose 1% 
8.92 8.98 9.14 
+0.54 +0.86 +0.89 
9.14 
•0.48 
8.57 
•0.72 
9.50 
+0.45 
8.75 
+0.87 
9.71 
+0.56 
8.20 
+0.64 
445* 452* 464* 
+ 36.4 + 4 1 . 6 + 42.4 
1082 1165 1239 
+ 104.2 + 115.3 + 120.5 
1072 892* 630 
+ 98.6 + 82.6 + 61.4 
1030 1046 
+102.5 + 79.4 
976.4 932.5 
+ 90.5 + 91.6 
982.4 995.4 1024 7.36 7.24 7.20 
+ 9 1 . 6 + 8 2 . 4 + 101.3 +0.49 +0.43 +0.65 
1022 
+ 92.4 
854.4 
+ 73.6 
7.18 
+0.69 
7.44 
+0.69 
7.24 
+0.35 
7.64 
+0.75 
7.35 
+0.45 
7.88 
+0.78 
High dose 2% 
8.75 8.57 8.00* 
+0.40 +0.82 +0.70 
1056 742* 592* -
+ 90.2 + 71.6 + 52.4 
996 1010 1021 
+ 90.6 + 88.4 +101.6 
7.36 7.28 7.12 
+0.72 +0.64 +0.61 
9.60 9.72 9.45 
Negative control 
Positive control 
ffl Low dose 1% 
High dose 2% 
+0.56 +0.64 +0.35 
9.56 
+0.92 
9.46 
+0.46 
9.78 
+0.90 
9.27 
+0.73 
9.70 
+0.95 
9.45 
+0.62 
9.49 9.62 9.80 
+0.94 +0.56 +0.64 
2540 
+ 195 
2560 
+ 208 
2510 
+ 242.6 
2546 2565 
+ 178 + 220.4 
2520 
+ 236.1 
2542 
+ 195.4 
2573 
+ 226.2 
2545 
+ 186.0 
2570 2542 2562 
+212.0 + 206 + 252.4 
1905 
+ 181.6 
1908 
+ 162.4 
1924 
f 135.7 
1936 
f 185.3 
1972 
+ 182.6 
1942 
+ 139.1 
1928 1964 1943 
+ 179.5 + 175.6 + 164.6 
1946 1952 1956 
+ 175.4 + 185.4 + 170.4 
6.43 
+0.43 
6.40 
+0.52 
6.25 
+0.42 
6.42 
+0.58 
6.37 
+0.59 
6.43 
+0.32 
6.16 
+0.60 
6.32 
+0.53 
6.56 
+0.43 
6.42 6.36 6.34 
+0.42 +0.56 +0.62 
Q 
—t 
03 
CO 
£D 
> 
o 
9. 
•—••' 
CD 
C/> 
* Values are significant relative to positive control (P<0.01) 
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Table III: Effect of administrating vaniline on spleen and heart lipids pattern of hypercholesterolemic rats. 
Treatments 
Total lipids 
gm/100 gm 
Cholesterol 
mg/100 gm 
Phospholipids 
mg/100 gm 
Time in weeks 
Triglyceride 
gm/100 gm 
< 
O 
4i-
Tl 
if) 
O 
CD 
CD 
Negative control 
2.35 
+0.21 
2.36 2.46 
+0.23 +0.24 
122* 143* 162* 
f 7.5 + 13.5 + 14.6 
812 835 866 
+ 66.4 + 75.6 + 80.4 
1.64 1.68 
+0.11 +0.14 
1.60* 
+0.13 
Positive control 
Low dose 1% 
High dose 2% 
Negative control 
Positive control 
Low dose 1% 
High dose 2% 
2 . 6 4 
+ 0 . 2 3 
2 . 5 6 
+ 0 . 2 4 
2 . 6 4 
+ 0 . 2 5 
2 . 8 6 
+ 0 . 2 5 
2 . 5 5 
+ 0 . 2 0 
2 . 5 6 
+ 0 . 2 5 
3 . 1 2 
+ 0 . 3 1 
2 . 5 2 
+ 0 . 2 1 
2 . 4 8 
+ 0 . 2 0 
325 382.5 405.6 
+ 2 9 . 4 + 2 0 . 5 + 3 2 . 5 
1.32 
+0.11 
1.28 
+0.09 
1.38 
+0.12 
1.48 
+ 0 . 1 3 
1.56 
+ 0 . 1 4 
1 . 
+ 0 . 
1 . 
+ 0 . 
. 5 6 
. 1 0 
. 5 2 
. 1 3 
1.84 
+ 0 . 1 8 
1.43-
+ 0 . 1 0 
1.54 1.46 1.44* 
+0.14 +0.11 ^ +0.13 
3 1 0 . 2 
• 2 8 . 5 
3 1 6 . 4 
• 2 5 . 6 
2 6 2 . 0 * 
+ 2 1 . 6 
265* 
+ 2 1 . 9 
242* 
+ 2 0 . 6 
230* 
+ 1 6 . 4 
132 138* 149* 
f 12.4 + 11.6 + 13.5 
2 1 8 . 5 
• 2 0 . 4 
2 1 2 . 5 
• 1 6 . 5 " 
2 0 6 . 4 
• 1 3 . 5 
2 3 9 
+ 2 0 . 4 
1 8 0 . 5 * 
+ 1 6 . 4 
1 9 0 . 4 * 
+ 1 7 . 3 
2 5 6 
+ 2 0 . 5 
1 7 3 . 6 * 
+ 1 6 . 4 
1 6 8 . 6 * 
+ 1 4 . 4 
784 732 714 
+ 61.4 + 71.2 + 70.2 
762 
+ 53.5 
7 8 4 
- 6 2 . 4 
7 9 9 
- 4 5 . 6 . 
8 1 2 
+ 8 0 . 3 
7 9 8 
+ 7 8 . 4 
792 
+ 49.6 
280 , 296* 315* 
+ 2 2 . 4 + 2 6 . 2 + 3 0 . 2 
246.5 224.6 210 
+ 2 3 . 6 + 2 0 . 5 + 1 9 . 4 
154 
2 0 . 5 
!48 
2 2 . 3 
2 6 4 
+ 1 6 . 3 
2 5 8 
+ 2 3 . 0 
2 6 8 * 
+ 1 8 . 4 
2 7 2 * 
+ 2 4 . 6 
1 . 7 7 
+ 0 . 1 6 
1 . 7 2 
+ 0 . 1 6 
1 . 8 2 
+ 0 . 1 8 
0 . 8 9 
+ 0 . 0 8 
1 . 2 0 
+ 0 . 1 0 
1 . 1 6 
+ 0 . 0 9 
1 . 1 6 
+ 0 . 1 3 
1 . 9 2 
+ 0 . 1 9 
1 . 7 2 
+ 0 . 1 4 
1 . 6 8 
+ 0 . 1 4 
0 . 9 5 * 
+ 0 . 0 7 
1 . 2 4 
+ 0 . 1 1 
1 . 0 9 
+ 0 . 1 0 
1 . 0 8 
+ 0 . 0 8 
2 . 0 8 
+ 0 . 2 0 
1 . 6 2 * 
+ 0 . 1 1 
1 . 6 3 * 
+ 0 . 1 6 
1 . 0 5 * 
+ 0 . 1 0 
1 . 4 2 
+ 0 . 1 3 
1 . 0 6 * 
+ 0 . 1 0 
1 . 0 4 * 
+ 0 . 0 9 
CO 
CO 
* Values are significant relative to positive control (P < 0.01). 
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Table IV: Effect of administrating Vanillin on the liver function of hypercholesterolemic rats. 
Treatments 
Acid phos. 
K.A. units/L. 
Alk. phos. 
K.A. units/L. 
GOT 
Mg pyruric acid/ml. serum 
Time in weeks 
GOT/GPT 4i^  
Negative 
control 
682* 6.99* 7.30* 
+0.54 +0.69 +0.72 
28.6 28.9* 
+2.64 +2.74 
29.5* 49.50 48.62* 51.60* 21.56* 20.82* 21.08* 2.29 2.34 2.45 
+ 2.54 + 3.95 + 4.26 + 4.82 + 2.16 + 1.64 + 1.82 +0.181 +0.23 +0.16 
Positive 
control 
8.52 9.98 11.82 
+0.74 +0.86 +1.15 
35.62 35.89 38.99 68.6 69.70 79.82 27.56 29.52 31 .6 
+ 3.16 + 3.21 + 2 .93 + 6.2 + 5.42 + 7.82 + 2.62 + 2.16 + 3 .01 
2 .48 2.36 2.52 
+0.81 +0.16 +0.24 
Low dose 
1% 
8.92 8.77 7.50* 
+0.87 +0.82 +0.72 
38.50 34.60 31.62* 
+ 3.32 + 3.16 + 3.01 
65.60 61.40 
+ 4.35 + 5.21 
58.6* 27.56 26.56 26.02* 2.38 2.31 2.25 
+ 5.42 + 2.07 + 1.8 + 1.64 +0.26 +0.91 +0.19 
High dose 
2% 
9.05 7.25* 6.50* 
+0.89 +0.62 +0.62 
34.64 32.76 30.56* 
+ 3 . 3 1 + 3 . 1 6 + 2 . 7 
64.30 60.8 
+ 3.62 + 4.35 
59.50* 26.60 24.06* 24 .65* 2.42 2 .53 2 .41 
+ 4 .32 + 1.86 + 2 .35 + 1.65 +0.20 +0.18 +0.18 
Values are significant relative to positive control (P < 0.01). 
Table V: Effect of administrating Vanillin on serum protein fraction and free amino acids of hypercholesterolemic rats. 
Treatments 
Negative 
control 
Positive 
control 
Low dose 
1% 
High dose 
2% 
Protein gm 
3 
7.16* 
+0.62 
9.02 
+0.45 
8.98 
+0.43 
8.75 
+0.52 
6 
7.45* 
+0.71 
9.82 
+0.92 
8.56 
+0.43 
8.45 
+0.56 
i/dl 
9 
7.56* 
+0.52 
10.20 
+0.64 
8.15* 
+0.78 
8.04* 
+0.64 
Albumin gm/dl 
3 
4.25 
+0.42 
4.65 
+0.38 
4.75 
+0.26 
4.82 
+0.38 
6 
4.35 
+0.37 
4.85 
+0.32 
4.62 
+0.26 
4.75 
+0.42 
9 
4.25 
+0.36 
4.92 
+0.35 
4.32 
+0.32 
4.28 
+0.42 
Glob 
3 
2.91* 
+0.26 
4.37 
+0.41 
4.83 
+0.42 
3.93 
+0.16 
(ulin gm/dl 
Time in 
6 
3.20* 
+0.28 
4.97 
+0.48 
3.94* 
+0.32 
3.70* 
+0.23 
weeks 
9 
3.31* 
+0.31 
5.28 
+0.35' 
3.83* 
+0.26 
3.76* 
+0.32 
3 . 
1.55* 
+0.12 
1.06 
+0.09 
0.98 
+0.07 
1.26 
+0.09 
Alb./ Glub 
6 
1.36* 
+0.11 
0.98 
+0.06 
1.17 
+0.08 
1.28 
+0.09 
9 
1.28* 
+0.08 
0.93 
+0.08 
1.13* 
+0.07 
1.14 
+0.09 
Free i 
3 
87.2* 
+ 7.2 
108.40 
+ 9.5 
108.0 
+ 9.6 
99.60 
+ 8.7 
amino acid 
6 
77.6* 
+ 7.0 
108.5 
+ 9.3 
88.2* 
+ 8.6 
84.4* 
+ 7.4 
Mg/dl 
9 
80.2* 
+ 5.6 
104. 5 
+ 8.5 
75.0* 
+ 7.2 
72.3* 
+ 6.3 
s 
> o 
CD 
CD 
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Table VI Effect of administrating Vaniline on kidney function of 
hypercholesterolemic rats. 
Treatments 
Creatinine (mg/dl) Uric acid (mg/dl) 
Time in weeks 
Negative control 
Positive control 
Low dose 1% 
High dose 2% 
0.88* 
+0.011 
1.10 
+0.012 
1.05 
+0.013 
1.08 
+0.012 
0.92* 
+0.011 
1.20 
+0.012 
1.00* 
+0.11 
1.02* 
+0.014 
0.95* 
+0.012 
1.23 
+0.012 
0.98* 
+0.010 
0.96* 
+0.01 
5.56 5.68 5.82 
+0.42 +0.55 +0.51 
6.08 6.21 6.18 
+0.35 +0.43 +0.60 
6.12 5.98 5.80 
+0.43 +0.52 +0.43 
6.07 5.70 5.90 
+0.58 +0.54 +0.58 
* Values are significant relative to positive control (P< 0.01), 
GPT activity. Fumarle and a-Ketoglutaric acids (in-
termediates of TCA) are converted to citrate. The 
latter substance is cleaved to oxalacetate and acetyl 
COA which serves as a precursor for lipid biosyn-
thesis. 
Treatment with Vanillin induced a significant 
decrease in the high activity of GPT, GOT, alkalin 
and acid phosphatase and the values were nearly 
attained to the initial level (negative control) after 
nine weeks of administration. The present study 
indicated that the administration of Vanillin might 
alter (improves) the activity of liver function enzy-
mes followed by changes in overall protein meta-
bolism. Accordingly, some of the absorbed amino 
acids were deaminated and the amino nitrogen 
excreted as urea. On this basis, a relation might 
exist between protein metabolism and the increa-
sed body fat content. 
Total serum protein, albumin, globulin and free 
amino acids of normal, hyper, and hypercholeste-
rolemic rats administrated Vanillin are shown in 
Table V. Hypercholesterolemic state was accom-
panied by a significant increase in total serum 
protein and globulin fraction but a slight increase 
was noticed in albumin fraction, followed by a 
remarkable decrease which nearly attained the initial 
level after administrating Vanillin. Also, hypercho-
lesterolemia was accompained by significant 
decrease in Alb./Globulin (A/G) ratio. Feeding on 
Vanillin slightly increased the A/G ratio but it still 
lower than the control group. The decrease in A/ 
G ratio was due to nonsignificant increase in albumin 
biosynthesis in the liver cells and /or the signifi-
cant increase in the globulin concentration. The 
obtained results agreed with the results in Table 
VI which revealed a significant increase in catabo-
lic products of protein as a result of hypercholes-
terolemic state, particularly uric acid and creatini-
ne. Uric acid is often associated with the increase 
of nucleic acid synthesis and breakdown. In this 
respect administration of Vanillin at low and high 
doses exertes potent anabolic effects for protein 
metabolism. 
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